Clinical trial
A Safety & Efficacy Clinical Study to Evaluate the Narrowing of the Renal…
NCT00209391 · GE Healthcare, Industry · Completed
Key facts
| NCT number | NCT00209391 |
|---|---|
| Title | A Safety & Efficacy Clinical Study to Evaluate the Narrowing of the Renal Arteries While Using Gadodiamide |
| Official title | A Multicentre, Phase 3, Open-Label, Controlled Study Evaluating the Efficacy and Safety of 0.1 mmol/kg OMNISCAN (Gadodiamide Injection) in Magnetic Resonance Angiography (MRA) of the Renal Arteries |
| Lead sponsor | GE Healthcare, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Renal Artery Stenosis |
| Intervention type | Drug |
| Interventions | Gadodiamide Injection |
| Enrollment | 395 |
| Start date | Sep 1, 2003 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Apr 25, 2019 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: